Ex Parte Carlson - Page 31


                 Appeal No.  2004-2317                                                         Page 31                   
                 Application No.  09/771,938                                                                             
                 physiological traits, or all of the genome, of the I015036 plant.  For the foregoing                    
                 reasons, however, this line of reasoning is not persuasive.                                             
                 III.  The single locus to be introduced:                                                                
                        The examiner finds (Answer, page 40), “the claims do not place any limit                         
                 on the single locus to be introduced” into I015036 plants.  The examiner                                
                 recognizes, however, that “[t]he prior art shows that hundreds of nucleotide                            
                 sequences encoding products that confer various types of plant traits have been                         
                 isolated at the time the instant invention was filed.”  Id.  In addition, the examiner                  
                 recognizes (id.), “[o]ne skilled in the art can transform any of these isolated                         
                 nucleotide sequences known in the prior art into a corn plant cell, and regenerate                      
                 a transgenic plant from the transformed cell.”                                                          
                        Nevertheless, the examiner finds (id.), “[u]ndue experimentation would be                        
                 required by one skilled in the art to isolate single loci that govern the traits                        
                 encompassed by the claims.”  In this regard, the examiner asserts (Answer, page                         
                 44) that the claims broadly encompass corn plants comprising any type of single                         
                 loci, including those that have not yet been identified or isolated.  To the extent                     
                 that the examiner is asserting that appellant has not provided an enabling                              
                 disclosure of single loci that have not been identified, we note that enablement                        
                 under 35 U.S.C. § 112, first paragraph is evaluated as of appellant’s filing date.                      
                 As set forth in Chiron Corp. v. Genentech Inc., 363 F.3d 1247, 1254, 70 USPQ2d                          
                 1321, 1325-26 (Fed. Cir. 2004), “a patent document cannot enable technology                             
                 that arises after the date of application.  The law does not expect an applicant to                     
                 disclose knowledge invented or developed after the filing date.  Such disclosure                        







Page:  Previous  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  Next 

Last modified: November 3, 2007